A Phase II Study of Gemcitabine/ Mitoxantrone in Patients With AML in First Relapse.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Gemcitabine; Mitoxantrone
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 22 Feb 2018 Biomarkers information updated
- 16 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.